Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity
Jheng-Yu Wu, Shengyan Xiang, Mu Zhang, et al.
Journal of Biological Chemistry (2017) Vol. 293, Iss. 6, pp. 1976-1993
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

HDAC6 as privileged target in drug discovery: A perspective
Sravani Pulya, Sk. Abdul Amin, Nilanjan Adhikari, et al.
Pharmacological Research (2020) Vol. 163, pp. 105274-105274
Closed Access | Times Cited: 179
HDAC6: A unique HDAC family member as a cancer target
Sumeet Kaur, Prerna Rajoria, Madhu Chopra
Cellular Oncology (2022) Vol. 45, Iss. 5, pp. 779-829
Closed Access | Times Cited: 55
Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma
Minjeong Yeon, Youngmi Kim, Hyun Suk Jung, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 52
HDAC9‐mediated calmodulin deacetylation induces memory impairment in Alzheimer's disease
Hailong Zhang, Shu‐Fen Hu, Pin Yang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 7
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine
María Scherma, Johanna S. Qvist, Arun Asok, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 18, pp. 9991-10002
Open Access | Times Cited: 47
Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors
Apostolia M. Tsimberidou, Philip Beer, Carrie Cartwright, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 13, pp. 3584-3594
Open Access | Times Cited: 40
The role of acetylation and deacetylation in cancer metabolism
Cuicui Wang, Xiaoxin Ma
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
Uveal Melanoma Cell Line Proliferation Is Inhibited by Ricolinostat, a Histone Deacetylase Inhibitor
Husvinee Sundaramurthi, Sandra García‐Mulero, Valentina Tonelotto, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 782-782
Open Access | Times Cited: 20
Histone deacetylase 6’s function in viral infection, innate immunity, and disease: latest advances
Min Qu, Huijun Zhang, Pengyuan Cheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
HDAC4 mediated LHPP deacetylation enhances its destabilization and promotes the proliferation and metastasis of nasopharyngeal carcinoma
Xueshuo Sun, Kun Zhang, Xingzhi Peng, et al.
Cancer Letters (2023) Vol. 562, pp. 216158-216158
Open Access | Times Cited: 11
Central inhibition of HDAC6 re-sensitizes leptin signaling during obesity to induce profound weight loss
Dongxian Guan, Yuqin Men, Alexander Bartlett, et al.
Cell Metabolism (2024) Vol. 36, Iss. 4, pp. 857-876.e10
Open Access | Times Cited: 4
Regulation of HDAC6 Catalytic Activity in Cancer: The Role of Post-Translational Modifications and Protein–Protein Interactions
Leen Asaad, Benjamin Pepperrell, Emma McErlean, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1274-1274
Open Access
Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitors
María Teresa Borrello, Dušan Ružić, Hannah L. Paish, et al.
FEBS Journal (2025)
Open Access
Unlocking the potential of novel Tetrahydro-β-Carboline-based HDAC6 inhibitors for colorectal Cancer therapy: Design, synthesis and biological evaluation
Noreen Hemida, Dalia S. El‐Gamil, Ahmed K. ElHady, et al.
Bioorganic Chemistry (2025), pp. 108454-108454
Closed Access
The unraveling of substrate specificity of histone deacetylase 6 domains using acetylome peptide microarrays and peptide libraries
Zsófia Kutil, L. Skultetyova, David Rauh, et al.
The FASEB Journal (2018) Vol. 33, Iss. 3, pp. 4035-4045
Open Access | Times Cited: 33
Histone deacetylase 6 promotes growth of glioblastoma through the MKK7/JNK/c‐Jun signaling pathway
Ziyan Huang, Yong Xia, Kunhua Hu, et al.
Journal of Neurochemistry (2019) Vol. 152, Iss. 2, pp. 221-234
Open Access | Times Cited: 31
The Role of Post-Translational Acetylation and Deacetylation of Signaling Proteins and Transcription Factors after Cerebral Ischemia: Facts and Hypotheses
Svetlana Demyanenko, Svetlana Sharifulina
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7947-7947
Open Access | Times Cited: 24
HDAC6 promotes growth, migration/invasion, and self-renewal of rhabdomyosarcoma
Thao Pham, Kristin Robinson, Lin Xu, et al.
Oncogene (2020) Vol. 40, Iss. 3, pp. 578-591
Open Access | Times Cited: 26
Regulation of ERK2 activity by dynamic S-acylation
Saara‐Anne Azizi, Tian Qiu, Noah Brookes, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113135-113135
Open Access | Times Cited: 8
HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?
Hélène Losson, Michaël Schnekenburger, Mario Dicato, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 318-318
Open Access | Times Cited: 22
Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9592-9592
Open Access | Times Cited: 13
Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer
Ana Vuletić, Katarina Mirjačić Martinović, Jelena Spasić
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 54-54
Open Access | Times Cited: 7
Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC)
Katja Schiedlauske, Alina Deipenbrock, Marc Pflieger, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 752-752
Open Access | Times Cited: 2
HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1
Niko Moses, Mu Zhang, Jheng-Yu Wu, et al.
Cells (2020) Vol. 9, Iss. 10, pp. 2237-2237
Open Access | Times Cited: 19
Enhancing Therapeutic Approaches for Melanoma Patients Targeting Epigenetic Modifiers
Maria Gracia-Hernandez, Zuleima Munoz, Alejandro Villagra
Cancers (2021) Vol. 13, Iss. 24, pp. 6180-6180
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top